Efficient CRISPR-Cas9 mediated gene disruption in primary erythroid progenitor cells

Affiliations

• ¹ Whitehead Institute for Biomedical Research, Cambridge, MA, USA Department of Pediatrics, Harvard Medical School, Boston, MA, USA Division of Hematology and Oncology, Boston Children's Hospital, Boston, MA, USA Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• ² Whitehead Institute for Biomedical Research, Cambridge, MA, USA.
• ³ Whitehead Institute for Biomedical Research, Cambridge, MA, USA Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA.
• ⁴ Whitehead Institute for Biomedical Research, Cambridge, MA, USA Departments of Biology and Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA lodish@wi.mit.edu.